Atea Pharmaceuticals, Inc. Common Stock

AVIRNASDAQ • USD
ThemeBiotech - Drug Development›Infectious Disease & Vaccines
5.35 USD
↗ 0.00 (0.00%)🟢PRE MARKET (AS OF 04:56 PM EDT)
🟢Market: OPEN
Open?$5.45
High?$5.55
Low?$5.34
Prev. Close?$5.36
Volume?136.9K
Avg. Volume?380.9K
VWAP?$5.43
Rel. Volume?0.36x
Bid / Ask
Bid?$4.69 × 100
Ask?$6.16 × 100
Spread?$1.47
Midpoint?$5.43
Valuation & Ratios
Market Cap?427.0M
Shares Out?79.7M
Float?54.5M
Float %?69.8%
P/E Ratio?N/A
P/B Ratio?1.55
EPS?-$1.99
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?7.82Strong
Quick Ratio?7.82Strong
Cash Ratio?2.41Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A▾
P/B?
1.55CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
-1.8CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
-57.5%WEAK▾
ROA?
-50.2%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$331.3M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
Employees
55
Market Cap
435.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.ateapharma.com
Listed
2020-10-30
Address
225 FRANKLIN STREET
BOSTON, MA 02110
Phone: (857) 284-8891
MarketsMoversWatchlist